Diacer 50 mg

Description

Diacer 50 mg is an ANVIS capsule product whose original carton identifies diacerein 50 mg. The photographed presentation contains thirty capsules. This page brings together the visible strength, dosage form and pack details alongside general ingredient safety information.

Diacer 50 mg product specification

• Labelled ingredients: Diacerein
• Strength information: 50 mg per capsule
• Dosage form: Capsules
• Pack presentation: 3 × 10 capsules (30 capsules)
• Brand: ANVIS

Ingredient background

Diacerein is a slow-acting medicine used for symptoms of osteoarthritis. European safety guidance limits its use to hip or knee osteoarthritis under experienced medical supervision. However, that guidance does not establish the complete specification or local approval of this particular brand. A clinician must assess suitability.

Important precautions

Severe diarrhoea and liver injury are important risks. European guidance says to stop diacerein if diarrhoea occurs and contact the doctor. It also advises against use in people with current or previous liver disease. In addition, it does not recommend diacerein for people aged 65 or older.

Discuss liver monitoring and any signs of liver problems, such as yellow skin or eyes. Also tell the prescriber about other medicines and existing health conditions. Follow the complete leaflet and the clinician’s directions for the supplied product. Do not select a daily regimen from the 50 mg strength alone.

Checking strength and presentation

First, match the full name and 50 mg concentration on the carton to the prescription. The three strips of ten capsules give thirty capsules in total. That quantity identifies the presentation, not a course length. Also check the complete label if a supplied pack has different wording.

Before use, inspect the blister seals, batch number and expiry date. Keep the capsules in their original packaging and follow the storage instructions. In addition, retain the carton and leaflet so that identification and directions remain available. Ask a pharmacist to check any damaged or unclear labelling before use.

Documentation and enquiries

For general ingredient background, read the EMA diacerein safety guidance. However, that source does not confirm the full specification of this ANVIS product. For further documentation or availability, contact ANVIS with the exact product name and presentation. Alternatively, browse the ANVIS product catalogue to compare other products.